Millipore Corporation Launches Ground-Breaking MilliPROBE(R) Solution to Detect Mycoplasma in Biopharmaceutical Manufacturing

BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced the launch of a new product from its ground-breaking collaboration with Roka Bioscience to develop faster, more robust tests for contaminants in pharmaceutical and biotechnology manufacturing. The MilliPROBE® Detection System for Mycoplasma is the first solution of its kind for the early detection of mycoplasma contamination in the highly regulated biopharmaceutical manufacturing industry.

MORE ON THIS TOPIC